First round to Amgen in EPO battle

Article Abstract:

US District Judge William Young rules in favor of Amgen in a erythropoietin patent infringement suit filed against Transkaryotic Therapies.

Drugs, Cellular Protein, In-Vitro Diagnostic Substance Manufacturing, Cellular proteins, Amgen Inc., AMGN, Transkaryotic Therapies Inc.

---

Gene pill patents a surprise for gene therapy

Article Abstract:

A gene pill composed of DNA encoding insulin has been patented by University of California researchers. The gene pill claims a novel method for lowering blood glucose.

Research and Development in the Physical, Engineering, and Life Sciences, Research and Testing Services, Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, California, Antidiabetic Preparations, Diabetes R&D, Hypoglycemic agents, Diabetes research

---

US FDA approves new class of HIV therapeutics

Article Abstract:

Hoffmann-La Roche's Fuzeon is the first synthetic peptide drug from a commercial enterprise. The US Food and Drug Administration approved the AIDS drug for 15,000 patients in 2003.

Product introduction, New Products/Services, Pharmaceutical industry, Hoffmann-La Roche Inc., AIDS treatment, Fuzeon (Medication)

Similar abstracts:

• Abstracts: High margin products promise to relieve the pain of opiates. Pfizer
• Abstracts: All it takes is money: As accountancy firms diversify and become more global, they are going to have to find new and inventive ways of funding their expansion
• Abstracts: US trends may lead to inflation surprise. Divorced from the dollar. The real threat to Wall Street
• Abstracts: Tech companies with minimal risk. Take a slice of their profits. Shares that must climb
• Abstracts: The sun rises in the east. Dining out. One for all?

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.